The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity ...

Investors increased their allocations to pharmaceuticals, banks, and industrials in November, according to the latest BofA ...

The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...

Farther Finance Advisors LLC grew its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) by 97.1% during the third quarter, HoldingsChannel reports.

We recommend buying CNYA ETF for its diversification, despite high expense ratio and valuation concerns. Read here for an ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Nippon India NIFTY Pharma ETF Growth Plan share price previously? Nippon India NIFTY Pharma ETF Growth Plan share ...

What is the category of Nippon India Nifty Pharma ETF ? The category of Nippon India Nifty Pharma ETF is Equity - Sector - Healthcare What is the current NAV of Nippon India Nifty Pharma ETF ...

Amgen Inc. (AMGN), headquartered in Thousand Oaks, California, discovers, develops, manufactures, and delivers human ...

Zooming in further, JNJ's performance trails behind the iShares U.S. Pharmaceuticals ETF (IHE), which has reported gains of 19.7% over the past 52 weeks and a 12.5% increase on a YTD basis.

Headquartered in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a biotechnology company specializing in messenger RNA ...